Sign up Australia
Proactive Investors - Run By Investors For Investors unit abandons plan to sell pharmaceutical products, CNBC says

Amazon found it difficult to persuade hospitals to change the way they purchase products box
Amazon Business failed to convince hospitals to change the way they purchase products Inc.'s (NASDAQ:AMZN) Business unit, which sells bulk items to companies, has abandoned a plan to sell pharmaceutical products after weighing it last year, according to a report by CNBC, citing people familiar with the matter.

Amazon Business’s decision is partly because it failed to persuade hospitals to change the way they purchase products and cut out middlemen from the deals, CNBC said.

Another issue was that Amazon Business would have had to build an extensive logistics network that could accomodate drugs and other pharmaceutical products, which are sensitive to temperature, according to the report.

The retreat from the pharmaceutical space was seen as favorable by investors in pharmacies. CVS Health Corp. gained 5.7% to US$67.00 in early afternoon trading, while the Walgreens Boots Alliance Inc., which owns Walgreens and Boots, jumped 4.1% to US$66.43.

Amazon Business may consider getting into pharmaceuticals again as it gains size, according to CNBC.

Shares of were up 0.64% at US$1,439.50.

View full AMZN profile View Profile Timeline

Related Articles

H&T Pawnbrokers store
July 02 2018
Last year the company saw gross profits jump 45% thanks to a booming personal loan book and robust sales of luxury second-hand watches and jewellery.
Flying Brands
July 17 2018
“We look forward to the future with confidence and excitement," said Flying Brands boss Trevor Brown.

No investment advice

The information on this Site is of a general nature only. It does not take your specific needs or circumstances into consideration, so you should look at your own financial position, objectives and requirements and seek financial advice before making any financial decisions. You acknowledge and understand that neither the Company, its related bodies corporate, the information providers or their affiliates will advise you personally about the nature, potential value or suitability of any particular security, portfolio of securities, transaction, investment strategy, or other matter. You should read our FSG and any other relevant disclosure documents and if necessary seek persona advice prior to making any investment decision.

You understand and agree that no Content (as defined below) published on the Site constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is suitable or advisable for any specific person.

You understand that in certain circumstances the Company, its related bodies corporate, the information providers or their affiliates may have received, or be entitled to receive, financial or other consideration in connection with promoting, and providing information about, certain entities on the Site and in communications otherwise provided to you.

You understand that price and other data is supplied by sources believed to be reliable, that the calculations herein are made using such data, and that neither such data nor such calculations are guaranteed by these sources, the Company, the information providers or any other person or entity, and may not be complete or accurate. From time to time, reference may be made in our marketing materials to prior articles and opinions we have published. These references may be selective, may reference only a portion of an article or recommendation, and are likely not to be current. As markets change continuously, previously published information and data may not be current and should not be relied upon.

Before you act on any general advice we provide, please consider whether it is appropriate for your personal circumstances.

© Proactive Investors 2018

Proactive Investors Australia PTY LTD ACN:132787654 ABN:19132787654.

Market Indices, Commodities and Regulatory News Headlines copyright © Morningstar. Data delayed 15 minutes unless otherwise indicated. Terms of use